Acute asthma episodes 1 actuation. A 2nd actuation may be required if an attack has not been relieved after 5 min. Prophylaxis of exercise-induced asthma 1-2 actuation/administration up to max: 8 actuation daily. Bronchial asthma & other conditions w/ reversible airways narrowing 1-2 actuation/administration up to max: 8 actuation daily.
Insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism, pheochromocytoma. Discontinue immediately if paradoxical bronchospasm occurs. Underlying severe heart disease. Severe asthma. Acute rapidly worsening dyspnoea. Patients on prolonged regular use must be evaluated for additional or increase of anti-inflammatory therapy. 1st trimester of pregnancy & lactation.
β-adrenergics, anticholinergics & xanthine derivatives may enhance the effects of Berotec. Increased risk of hypokalemia w/ xanthine derivatives, corticosteroids & diuretics. Serious reduction in bronchodilatation w/ concurrent administration w/ β-blockers. Enhanced action of β-adrenergic agonists w/ MAOIs or TCAs. Inhalation of halogenated hydrocarbon anesth may increase susceptibility to CV effects of β-agonists.
R03AC04 - fenoterol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Sign Out
